Can a new drilling technique make dental implants safer for people with thin jawbone?

NCT ID NCT07719283

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This trial tests two methods of sinus floor elevation—a procedure to create bone for dental implants in the upper jaw—in people with only 4-5 mm of bone below the sinus. One method uses a special rotating bur (osseodensification), the other uses manual tools (osteotomes). All procedures are monitored with a tiny camera (endoscope) to reduce the risk of tearing the sinus membrane. The goal is to see which technique leads to better bone healing, implant stability, and patient comfort.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
osseodensification drilling technique and osteotome technique for sinus floor elevation
What this could lead to
If osseodensification proves superior, it could offer a safer, more comfortable way to place dental implants in patients with limited sinus bone, reducing complications like membrane perforation.
What could go wrong
This is a small, early-stage trial with only 44 participants, so results may not apply broadly. Both techniques carry risks such as infection, bleeding, or implant failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 44 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Sep 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: * \>18 years old * Ability and willingness to comply with the study protocol and scheduling * Unilateral or bilateral absence of 2-3 consecutive teeth posterior to maxillary the 1st premolar (excluding 3rd molars) * Missing teeth extracted or lost \> 6months prior to surgery * Subsinus residual bone height 4-5 mm * Alveolar ridge bucco-palatal width allowing placement of implants with at least 3.7-mm diameter leaving \>1.5 mm at the buccal and palatal aspects of the implants * Narrow-medium sinus cavities with bucco-palatal width ≤ 15 mm at the 10-mm level including the residual alveolar crest * Sinus membrane thickness \< 2 mm Exclusion criteria: * Smoking \> 10 cigarettes/day * Absolute contraindications to implant therapy * Pregnancy or lactation * Systemic conditions/ medications affecting bone healing * Ongoing or history of head and neck irradiation therapy * Uncontrolled diabetes with HbA1c \> 7% * Alcohol or drug abuse * Ongoing or history of benign paroxysmal positional vertigo * Severe parafunctional habits (clenching and bruxism) * Maxillary sinus infection or pathology * Previous bone augmentation at the planned implant sites * Osseous lesions or infections at the planned implant sites * Sinus bony septa in line with the planned implant sites * Untreated periodontal disease

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Osseodensification drilling technique are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Saint Joseph University

    Beirut, Lebanon

More trials for these conditions

Other studies related to the condition(s) this trial covers.